For subscribers
Cancer patients previously fully covered by MediSave, MediShield Life may need to pay out of pocket
Sign up now: Get ST's newsletters delivered to your inbox
Since September, cancer treatment claims have been split – with separate claim limits for drugs and services.
PHOTO ILLUSTRATION: PEXELS
Follow topic:
SINGAPORE – Ms W was diagnosed with third-stage ovarian cancer in October 2020 and is being treated at the National University Cancer Institute as a subsidised patient.
Her treatment cost was fully covered by national insurance scheme MediShield Life and national medical savings scheme MediSave, until December 2022, when she had to top up $268.50 in cash. This came as a shock.
